Market Analysis and Insights: Global Fertility Services Market
Fertility is the natural capability to produce offspring. As a measure, fertility rate is the number of offspring born per mating pair, individual or population. Fertility differs from fecundity, which is defined as the potential for reproduction (influenced by gamete production, fertilization and carrying a pregnancy to term). A lack of fertility is infertility while a lack of fecundity would be called sterility.
The global Fertility Services market size is projected to reach US$ 19030 million by 2030, from US$ 11410 million in 2022, at a CAGR of 7.1% during 2023-2030.
The underlying causes covered in the fertility services market report include male and female infertility. Among the two, female infertility is likely to be the dominant segment over the forecast period. Factors credited to the success of the segment include the prevalence of obesity, elapsed age of motherhood, endometrial tuberculosis, and other medical conditions.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Fertility Services market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Fertility Services market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Fertility Services market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Fertility Services market.
Global Fertility Services Scope and Market Size
Fertility Services market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Fertility Services market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2030.
Segment by Type
Infertility Drugs
Assisted Reproductive Technology (ART)
Segment by Application
Male
Female
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck (Germany)
Cook Medical (U.S.)
Irvine Scientific (U.S.)
CooperSurgical (U.S.)
CARE Fertility Group (U.K.)
Ferring Pharmaceuticals (U.S.)
Vitrolife (U.S.)
Monash IVF Group (Australia)
